Advances in prevention and management of central line-associated bloodstream infections in patients with cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25352628.
- Also identified by DOI 10.1093/cid/ciu670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Central lines, which are essential for treating cancer, are associated with at least 400,000 episodes of bloodstream infection in patients with cancer every year in the United States. Effective novel interventions for preventing and managing these infections include antimicrobial-coated catheters and antimicrobial lock solutions.
Medical subject headings
- Bacteremia
- Catheterization, Central Venous
- Neoplasms